Date

Thursday, June 22, 2017

Venue

PT Merck Sharp Dohme Pharma TBK
Wisma BNI 46, Lantai 27
Jl. Jend. Sudirman Kav. 1
Jakarta

Time

10:00 WIB

Agenda

1. Approval to the Company's Annual Report on the Company's Business Activities and the Financial Administration of the Company for the Fiscal Year ended on  December 31, 2016.

2. Ratification to the Company's Balance Sheet and Income statement for the Fiscal Year ended on December 31, 2016 which has been audited by Public Accounting Firm, Tanudiredja, Wibisana & Rekan.

3. The utilization of Net Income for the Fiscal Year endied on December  31, 2016.

4. The appointment of a Public Accounting Firm that will audit the Company's Financial Statements for the Fiscal Year ended on December 31, 2017, with the consideration to the proposals of the Board of Commissioners of the Company, and determining the honorarium amount for Public Accounting Firm.

MERK - PT. Merck Tbk

Rp 3.570

-10 (-0,28%)